口服脊髓灰质炎疫苗运动对总体健康的影响:几内亚比绍农村地区的分组随机试验。

IF 14.3 1区 医学 Q1 INFECTIOUS DISEASES Journal of Infection Pub Date : 2024-09-30 DOI:10.1016/j.jinf.2024.106302
Line M. Nanque , Anshu Varma , Sanne M. Thysen , Christine S. Benn , Justiniano SD Martins , Aksel KG Jensen , Claudino Correia , Sören Möller , Anita Van den Biggelaar , Peter Aaby , Ane B. Fisker
{"title":"口服脊髓灰质炎疫苗运动对总体健康的影响:几内亚比绍农村地区的分组随机试验。","authors":"Line M. Nanque ,&nbsp;Anshu Varma ,&nbsp;Sanne M. Thysen ,&nbsp;Christine S. Benn ,&nbsp;Justiniano SD Martins ,&nbsp;Aksel KG Jensen ,&nbsp;Claudino Correia ,&nbsp;Sören Möller ,&nbsp;Anita Van den Biggelaar ,&nbsp;Peter Aaby ,&nbsp;Ane B. Fisker","doi":"10.1016/j.jinf.2024.106302","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To investigate in a cluster-randomised trial whether a campaign with oral polio vaccine (C-OPV) reduced mortality and morbidity.</div></div><div><h3>Methods</h3><div>We randomised 222 village clusters under demographic surveillance to an intervention (health check and C-OPV) or control group (health check only). Children aged 0–8 months were eligible. In Cox proportional hazards models with age as the underlying timescale, we compared rates of non-accidental mortality/hospital admission (composite primary outcome) during 12 months of follow-up. Secondary analyses considered non-accidental admission and mortality as separate outcomes. Potential effect modifiers identified in prior studies including sex, season, and timing of the first routine OPV dose (OPV0, scheduled at birth) were assessed.</div></div><div><h3>Results</h3><div>Among 10,175 children (5288 in 111 intervention clusters/4887 in 111 control clusters), we observed 265 deaths/admissions during 7616 person-years at risk (intervention: 129; control: 136). C-OPV did not reduce the composite endpoint, hazard ratio (HR): 0.87, 95%CI: 0.68–1.12 or its separate components. C-OPV reduced the risk in children receiving OPV0&lt;15 days of birth (HR=0.66, 95%CI: 0.46–0.95), but not in other children (p for interaction: 0.03). Interactions for other potential effect modifiers were not statistically significant.</div></div><div><h3>Conclusions</h3><div>C-OPV had no overall effect on mortality/admissions, but the effect differed by early priming with OPV0.</div></div>","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":"89 6","pages":"Article 106302"},"PeriodicalIF":14.3000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of a campaign with oral polio vaccine on general health: A cluster-randomised trial in rural Guinea-Bissau\",\"authors\":\"Line M. Nanque ,&nbsp;Anshu Varma ,&nbsp;Sanne M. Thysen ,&nbsp;Christine S. Benn ,&nbsp;Justiniano SD Martins ,&nbsp;Aksel KG Jensen ,&nbsp;Claudino Correia ,&nbsp;Sören Möller ,&nbsp;Anita Van den Biggelaar ,&nbsp;Peter Aaby ,&nbsp;Ane B. Fisker\",\"doi\":\"10.1016/j.jinf.2024.106302\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>To investigate in a cluster-randomised trial whether a campaign with oral polio vaccine (C-OPV) reduced mortality and morbidity.</div></div><div><h3>Methods</h3><div>We randomised 222 village clusters under demographic surveillance to an intervention (health check and C-OPV) or control group (health check only). Children aged 0–8 months were eligible. In Cox proportional hazards models with age as the underlying timescale, we compared rates of non-accidental mortality/hospital admission (composite primary outcome) during 12 months of follow-up. Secondary analyses considered non-accidental admission and mortality as separate outcomes. Potential effect modifiers identified in prior studies including sex, season, and timing of the first routine OPV dose (OPV0, scheduled at birth) were assessed.</div></div><div><h3>Results</h3><div>Among 10,175 children (5288 in 111 intervention clusters/4887 in 111 control clusters), we observed 265 deaths/admissions during 7616 person-years at risk (intervention: 129; control: 136). C-OPV did not reduce the composite endpoint, hazard ratio (HR): 0.87, 95%CI: 0.68–1.12 or its separate components. C-OPV reduced the risk in children receiving OPV0&lt;15 days of birth (HR=0.66, 95%CI: 0.46–0.95), but not in other children (p for interaction: 0.03). Interactions for other potential effect modifiers were not statistically significant.</div></div><div><h3>Conclusions</h3><div>C-OPV had no overall effect on mortality/admissions, but the effect differed by early priming with OPV0.</div></div>\",\"PeriodicalId\":50180,\"journal\":{\"name\":\"Journal of Infection\",\"volume\":\"89 6\",\"pages\":\"Article 106302\"},\"PeriodicalIF\":14.3000,\"publicationDate\":\"2024-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0163445324002366\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0163445324002366","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

目的通过分组随机试验调查口服脊髓灰质炎疫苗(C-OPV)是否能降低死亡率和发病率:我们将 222 个接受人口监测的村庄集群随机分为干预组(健康检查和 C-OPV)或对照组(仅健康检查)。0-8个月大的儿童均符合条件。在以年龄为基本时间尺度的 Cox 比例危险模型中,我们比较了 12 个月随访期间的非意外死亡率/入院率(综合主要结果)。二次分析将非意外入院率和死亡率作为单独的结果。我们还评估了先前研究中发现的潜在影响因素,包括性别、季节和首次常规接种 OPV 的时间(OPV0,计划在出生时接种):在 10,175 名儿童(111 个干预群组中的 5,288 人/111 个对照群组中的 4,887 人)中,我们观察到在 7,616 个风险年中有 265 人死亡/入院(干预群组:129 人;对照群组:136 人)。C-OPV 没有降低综合终点(危险比 (HR):0.87,95%CI:0.68-1.12)或其单独组成部分。结论:C-OPV降低了接受OPV的儿童的风险:结论:C-OPV对死亡率/入院率没有总体影响,但效果因早期接种OPV0而异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Effect of a campaign with oral polio vaccine on general health: A cluster-randomised trial in rural Guinea-Bissau

Objectives

To investigate in a cluster-randomised trial whether a campaign with oral polio vaccine (C-OPV) reduced mortality and morbidity.

Methods

We randomised 222 village clusters under demographic surveillance to an intervention (health check and C-OPV) or control group (health check only). Children aged 0–8 months were eligible. In Cox proportional hazards models with age as the underlying timescale, we compared rates of non-accidental mortality/hospital admission (composite primary outcome) during 12 months of follow-up. Secondary analyses considered non-accidental admission and mortality as separate outcomes. Potential effect modifiers identified in prior studies including sex, season, and timing of the first routine OPV dose (OPV0, scheduled at birth) were assessed.

Results

Among 10,175 children (5288 in 111 intervention clusters/4887 in 111 control clusters), we observed 265 deaths/admissions during 7616 person-years at risk (intervention: 129; control: 136). C-OPV did not reduce the composite endpoint, hazard ratio (HR): 0.87, 95%CI: 0.68–1.12 or its separate components. C-OPV reduced the risk in children receiving OPV0<15 days of birth (HR=0.66, 95%CI: 0.46–0.95), but not in other children (p for interaction: 0.03). Interactions for other potential effect modifiers were not statistically significant.

Conclusions

C-OPV had no overall effect on mortality/admissions, but the effect differed by early priming with OPV0.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Infection
Journal of Infection 医学-传染病学
CiteScore
45.90
自引率
3.20%
发文量
475
审稿时长
16 days
期刊介绍: The Journal of Infection publishes original papers on all aspects of infection - clinical, microbiological and epidemiological. The Journal seeks to bring together knowledge from all specialties involved in infection research and clinical practice, and present the best work in the ever-changing field of infection. Each issue brings you Editorials that describe current or controversial topics of interest, high quality Reviews to keep you in touch with the latest developments in specific fields of interest, an Epidemiology section reporting studies in the hospital and the general community, and a lively correspondence section.
期刊最新文献
Monocyte transcriptome signatures of inflammation and enhanced neutrophil recruitment characterize immunopathology in the blood of TB patients. Risk of invasive pneumococcal disease during pregnancy and postpartum and association with adverse maternal and foetal outcomes: a prospective cohort study, England, 2014-19. Comparison of two rapid host-response tests for distinguishing bacterial and viral infection in adults with acute respiratory infection. The effect of pre-COVID and post-COVID vaccination on long COVID: a systematic review and meta-analysis. Impact of Respiratory Syncytial Virus (RSV) on adult haematology oncology patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1